Soud and Pharma - if you are using the numbers from the 4C's to determine profitability I would put some question marks on your assumptions. Lets wait for the 6 monthly report with a proper revenue statement and then we can determine whether or not we are profitable.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid's Evolis Patent to be Granted in China
Ann: Cellmid's Evolis Patent to be Granted in China, page-40
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $9.19K | 1.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 600000 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 818778 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 600000 | 0.006 |
4 | 1166833 | 0.005 |
2 | 525000 | 0.004 |
1 | 600000 | 0.003 |
1 | 250000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 818778 | 3 |
0.008 | 380199 | 2 |
0.010 | 150000 | 2 |
0.012 | 290100 | 2 |
0.014 | 445077 | 2 |
Last trade - 14.31pm 21/05/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online